The National Health Insurance Administration (NHIA) yesterday announced that 18 types of medication, including 11 types of new drugs, are to be added to National Health Insurance (NHI) coverage, and that it is expected to benefit more than 14,000 patients.
According to a consensus reached by the Pharmaceutical Benefit and Reimbursement Scheme joint committee meeting held on Dec. 21 last year, three new drugs for treating cancer, three drugs for treating rare diseases and five other new drugs, as well as seven other drugs are to be covered by the NHI, the agency said.
The three new cancer drugs are abemaciclib, a targeted drug for the treatment of early-stage breast cancer, sacituzumab govitecan, a monoclonal antibody drug conjugate for treating triple-negative breast cancer, and polatuzumab vedotin, an antibody-drug conjugate for treating diffuse large B-cell lymphoma.
Photo: Chiu Chih-jou, Taipei Times
NHIA Medical Review and Pharmaceutical Benefits Division head Huang Yu-wen (黃育文) said adding abemaciclib as adjuvant therapy in early breast cancer patients with high risk of recurrence could reduce the risk of recurrence by 30 percent, and it is expected to benefit up to 2,150 people.
As there are few treatment options for triple-negative breast cancer, sacituzumab govitecan was included for patients who have received at least two sessions of systemic chemotherapy, but the tumor still has not been removed, no matter if they are a BRCA-mutant breast cancer patient or not, she said.
Although chemotherapy and stem cell transplantation is still the recommended treatment for diffuse large B-cell lymphoma patients, some patients cannot undergo a transplant nor chimeric antigen receptor T-cell therapy, so polatuzumab vedotin has been included to give them another option.
Other drugs for treating cancer that are to be covered include the dabrafenib-trametinib drug combination for treating patients with braf V600E-mutant advanced non-small cell lung cancer, and obinutuzumab for treating patient with chronic lymphocytic leukemia, the agency said.
They also include bevacizumab for the treatment of non-small cell lung cancer, ovarian cancer, fallopian tube cancer or peritoneal cancer; and ibrutinib for the treatment of chronic lymphocytic leukemia, it said.
Stiripentol for the treatment of seizures in people with Dravet syndrome and cannabidiol for the treatment of epilepsy related to Dravet syndrome or tuberous sclerosis complex were also approved, Huang said, adding that cannabidiol is a controlled drug that is recommended as a backup treatment option.
Apremilast oral tablets for the treatment of plaque psoriasis were also included, and compared with some other systemic therapies, they are considered less likely to cause liver injuries, which would be a safer option, she said.
The NHIA said the inclusion of the 18 types of medication into NHI coverage is expected to benefit more than 14,554 patients and that they would be available from next month at the earliest.
Additional reporting by CNA
‘CHARM OFFENSIVE’: Beijing has been sending senior Chinese officials to Okinawa as part of efforts to influence public opinion against the US, the ‘Telegraph’ reported Beijing is believed to be sowing divisions in Japan’s Okinawa Prefecture to better facilitate an invasion of Taiwan, British newspaper the Telegraph reported on Saturday. Less than 750km from Taiwan, Okinawa hosts nearly 30,000 US troops who would likely “play a pivotal role should Beijing order the invasion of Taiwan,” it wrote. To prevent US intervention in an invasion, China is carrying out a “silent invasion” of Okinawa by stoking the flames of discontent among locals toward the US presence in the prefecture, it said. Beijing is also allegedly funding separatists in the region, including Chosuke Yara, the head of the Ryukyu Independence
UNITED: The premier said Trump’s tariff comments provided a great opportunity for the private and public sectors to come together to maintain the nation’s chip advantage The government is considering ways to assist the nation’s semiconductor industry or hosting collaborative projects with the private sector after US President Donald Trump threatened to impose a 100 percent tariff on chips exported to the US, Premier Cho Jung-tai (卓榮泰) said yesterday. Trump on Monday told Republican members of the US Congress about plans to impose sweeping tariffs on semiconductors, steel, aluminum, copper and pharmaceuticals “in the very near future.” “It’s time for the United States to return to the system that made us richer and more powerful than ever before,” Trump said at the Republican Issues Conference in Miami, Florida. “They
GOLDEN OPPORTUNITY: Taiwan must capitalize on the shock waves DeepSeek has sent through US markets to show it is a tech partner of Washington, a researcher said China’s reported breakthrough in artificial intelligence (AI) would prompt the US to seek a stronger alliance with Taiwan and Japan to secure its technological superiority, a Taiwanese researcher said yesterday. The launch of low-cost AI model DeepSeek (深度求索) on Monday sent US tech stocks tumbling, with chipmaker Nvidia Corp losing 16 percent of its value and the NASDAQ falling 612.46 points, or 3.07 percent, to close at 19,341.84 points. On the same day, the Philadelphia Stock Exchange Semiconductor Sector index dropped 488.7 points, or 9.15 percent, to close at 4,853.24 points. The launch of the Chinese chatbot proves that a competitor can
‘VERY SHALLOW’: The center of Saturday’s quake in Tainan’s Dongshan District hit at a depth of 7.7km, while yesterday’s in Nansai was at a depth of 8.1km, the CWA said Two magnitude 5.7 earthquakes that struck on Saturday night and yesterday morning were aftershocks triggered by a magnitude 6.4 quake on Tuesday last week, a seismologist said, adding that the epicenters of the aftershocks are moving westward. Saturday and yesterday’s earthquakes occurred as people were preparing for the Lunar New Year holiday this week. As of 10am yesterday, the Central Weather Administration (CWA) recorded 110 aftershocks from last week’s main earthquake, including six magnitude 5 to 6 quakes and 32 magnitude 4 to 5 tremors. Seventy-one of the earthquakes were smaller than magnitude 4. Thirty-one of the aftershocks were felt nationwide, while 79